Bimzelx
Bimzelx ingredients
| Active ingredient | Strength |
|---|---|
| Bimekizumab | 160 mg/mL, 320 mg/2mL |
What Bimzelx is used for
The FDA lists the approved uses on the official label (below). In the EU, bimekizumab is approved as Bimzelx for:
Plaque psoriasis Bimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. Psoriatic arthritis Bimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (DMARDs). Axial spondyloarthritis Non-radiographic axial spondyloarthritis (nr-axSpA) Bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (NSAIDs). Ankylosing spondylitis (AS, radiographic axial spondyloarthritis) Bimzelx is i…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Bimzelx
- Generic name
- Bimekizumab
- Made by
- UCB, Inc.
- Forms
- Injection, Solution
- Given
- Subcutaneous
- FDA approval
- Biologic licence (BLA) BLA761151
- On the US market since
- 2023
Official information
- Bimzelx prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Bimekizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Bimzelx?
Bimzelx (Bimekizumab) is a specialist medicine made by UCB, Inc., approved by the US FDA.
What are the ingredients of Bimzelx?
Bimzelx contains Bimekizumab (160 mg/mL, 320 mg/2mL).
Is Bimzelx approved in Europe?
The same active substance is approved in the EU as Bimzelx.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA